XM اپنی سروسز امریکہ کے شہریوں کو فراہم نہیں کرتا ہے۔
G
G

Gilead


خبر

U.S. STOCKS Gold miners, Nikola, Cruise stocks

BUZZ-U.S. STOCKS ON THE MOVE-Gold miners, Nikola, Cruise stocks Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Chip stocks boosted the Nasdaq on Monday, while the S&P 500 and the Dow edged lower as investors awaited a key inflation reading, commentary from Federal Reserve Chair Jerome Powell and the start of corporate earnings season for monetary policy cues.
C
G
I
J
N
Q
T
U
U
R
S
V
F
M

U.S. STOCKS Ally Financial, Ideaya Biosciences, Brinker

BUZZ-U.S. STOCKS ON THE MOVE-Ally Financial, Ideaya Biosciences, Brinker Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The Nasdaq and the S&P 500 hit record highs on Monday, while the Dow scaled a more than one-month high as investors awaited a key inflation report, Congressional testimony from Federal Reserve Chair Jerome Powell and the start of earnings season this week.
B
C
G
I
J
N
Q
T
U
U
H
S
V
F
M

U.S. STOCKS Boeing, Gilead Sciences, Bumble

BUZZ-U.S. STOCKS ON THE MOVE-Boeing, Gilead Sciences, Bumble Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes were on track for a listless open on Monday, in a week packed with crucial inflation readings, Congressional testimony from Federal Reserve Chair Jerome Powell and the start of the corporate earnings season.
B
G
T
U
H
S
F

Gilead Sciences rises as brokerage upgrades to 'outperform'

BUZZ-Gilead Sciences rises as brokerage upgrades to 'outperform' ** Gilead Sciences' GILD.O shares rise 3.1% to $68.74 premarket ** Brokerage Raymond James raises its rating on company's shares to "outperform" from "market perform" ** Outstanding data from a study of Gilead's long-acting drug lenacapavir in HIV and expected approval of liver diseas
G

Nasdaq top and bottom performing stocks at about 03:45 p.m. EDT

BUZZ - Nasdaq top and bottom performing stocks at about 03:45 p.m. EDT Nasdaq 100 .NDX Top Performers Percent Change Tesla Inc TSLA.OQ +6.5% NVIDIA Corp NVDA.OQ +4.6% Broadcom Inc AVGO.OQ +4.3% Micron Technology Inc MU.OQ +3.2% Arm Holdings PLC ARM.OQ +2.9% Bottom Performers Percent Change Walgreens Boots Alliance Inc WBA.OQ -4.1% Gilead Sciences Inc GILD.OQ -2.6% Regeneron Pharmaceuticals Inc REGN.OQ -2.0% Biogen Inc BIIB.OQ -1.8% O'Reilly Automotive Inc ORLY.OQ -1.6% The Nasdaq 100 .NDX gained
B
B
G
M
N
R
T
W
U

S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT

BUZZ - S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT S&P 500 .SPX Top Performers Percent Change Paramount Global PARA.OQ +6.9% First Solar Inc FSLR.OQ +6.6% Tesla Inc TSLA.OQ +6.5% Vistra Corp VST.N +4.6% NVIDIA Corp NVDA.OQ +4.6% Bottom Performers Percent Change Walgreens Boots Alliance Inc WBA.OQ -4.1% Constellation Brands Inc
G
N
T
W
U

Cellares Kite, A Gilead Company, Will Evaluate Co's Automated Manufacturing Platform Cell Shuttle

BRIEF-Cellares Kite, A Gilead Company, Will Evaluate Co's Automated Manufacturing Platform Cell Shuttle June 27 (Reuters) - Gilead Sciences Inc GILD.O : CELLARES: KITE, A GILEAD COMPANY, WILL EVALUATE CO'S AUTOMATED MANUFACTURING PLATFORM CELL SHUTTLE Source text for Eikon: ID:nBw10TJNsa Further company coverage: GILD.O
G

U.S. stocks weekly: Heat advisory

RPT-BUZZ-U.S. stocks weekly: Heat advisory Repeats from Friday with no changes to text. Updates chart ** S&P 500 .SPX gains third consecutive week, advances 0.6% .N ** Indeed, benchmark index heating up just as summer solstice hits ** And Nasdaq .IXIC ekes out third-straight weekly gain, though it may be flying on fumes ** Most sectors toasty; Consumer Discretionary and Energy bake most, while Tech and bond-proxies cool off; this, as Growth .IGX was on pace for its best month vs Value .IVX in 24
A
A
G
M
N
U
U

U.S. CarMax, Eli Lilly, MicroStrategy

U.S. RESEARCH ROUNDUP-CarMax, Eli Lilly, MicroStrategy June 24 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including CarMax, Eli Lilly and MicroStrategy, on Monday. HIGHLIGHTS * CarMax Inc KMX.N : RBC raises target price to $75 from $73 * Eli Lilly LLY.N : Jefferies raises target price to $1,015 from $994 * MicroStrategy Inc MSTR.O : Canaccord Genuity cuts target price to $1,826 from $2,047 * Sharecare Inc SHCR.O : Canacco
A
A
B
D
G
M
N
V
E
F
T
E
P
R
T
C
C
I

U.S. stocks weekly: Heat advisory

BUZZ-U.S. stocks weekly: Heat advisory ** S&P 500 .SPX gains third consecutive week, advances 0.6% .N ** Indeed, benchmark index heating up just as summer solstice hits ** And Nasdaq .IXIC ekes out third-straight weekly gain, though it may be flying on fumes ** Most sectors toasty; Consumer Discretionary and Energy bake most, while Tech and bond-proxies cool off; this, as Growth .IGX was on pace for its best month vs Value .IVX in 24 years, before stumbling relatively last 3 trading days of the
A
A
G
M
N
U
U

U.S. STOCKS FactSet, Ryan Specialty, Sarepta

BUZZ-U.S. STOCKS ON THE MOVE-FactSet, Ryan Specialty, Sarepta Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street was set for a muted open on Friday as chip stocks lost ground, with focus on data from the manufacturing and services sectors for more clues on the health of the world's largest economy.
A
B
C
G
M
N
N
U
U
C
F

U.S. STOCKS Apple, Gilead, Spirit Aerosystems

BUZZ-U.S. STOCKS ON THE MOVE-Apple, Gilead, Spirit Aerosystems Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock index futures edged lower on Friday as megacap tech and chip stocks lost ground, with investors awaiting manufacturing and services sectors surveys for more clues on the health of the world's largest economy.
A
B
G
M
N
N
S
R
U
E
C

Wall Street set for muted open as investors await business survey data

US STOCKS-Wall Street set for muted open as investors await business survey data For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window Spirit Aero up following report of Boeing nearing buyout deal Sarepta surges on expanded use of gene therapy Gilead gains after long-acting HIV drug trial success S&P 500 crossed 5,500 points on Thursday Futures down: Dow 0.12%, S&P 500 0.08%, Nasdaq 0.01% Updated at 8:45 a.m.
A
B
G
M
N
Q
U
U
U

Gilead set to extend gains on success of long-acting HIV drug trial

BUZZ-Gilead set to extend gains on success of long-acting HIV drug trial Updates ** Shares of drugmaker Gilead Sciences GILD.O rise 3.2% to $70.7 premarket following HIV drug trial success reported on Thursday ** Stock closed 5% higher a day earlier on the news, after rising as much as 8.5% during the session ** Co's late-stage study showed injectable drug lenacapavir was more effective in preventing HIV infection in women versus its existing daily pill Truvada ** There were zero incidents of HI
G

Wall Street futures muted ahead of business survey data

US STOCKS-Wall Street futures muted ahead of business survey data For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window Spirit Aero up following report of Boeing nearing buyout deal Sarepta surges on expanded use of gene therapy Gilead gains after long-acting HIV drug trial success Futures: Dow, S&P 500, Nasdaq flat Updated at 7:29 a.m.
B
G
M
M
N
Q
U
U
U

U.S. STOCKS Apple, Gilead, Spirit Aerosystems

BUZZ-U.S. STOCKS ON THE MOVE-Apple, Gilead, Spirit Aerosystems Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock index futures edged lower on Friday as megacap tech and chip stocks lost ground, with investors awaiting manufacturing and services sectors surveys for more clues on the health of the world's largest economy.
A
B
G
M
N
N
R
U
C

Wall Street futures edge lower ahead of business survey data

US STOCKS-Wall Street futures edge lower ahead of business survey data For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window Futures lower: Dow 0.07%, S&P 500 0.15%, Nasdaq 0.12% June 21 (Reuters) - U.S. stock index futures edged lower on Friday as megacap tech and chip stocks lost ground, with investors awaiting manufacturing and services sectors surveys for more clues on the health of the world's largest economy.
A
B
G
M
N
Q
U
U
U

Gilead up over long-acting HIV drug trial success

BUZZ-Gilead up over long-acting HIV drug trial success ** Shares of drugmaker Gilead Sciences GILD.O rise 7.3% to $73.5 premarket over Thursday's HIV drug trial success ** Co's late-stage study showed its injectable drug, lenacapavir, was more effective in preventing HIV infection in women versus its existing daily pill Truvada, sending GILD's shar
G

Nasdaq top and bottom performing stocks at about 03:45 p.m. EDT

BUZZ - Nasdaq top and bottom performing stocks at about 03:45 p.m. EDT Nasdaq 100 .NDX Top Performers Percent Change Gilead Sciences Inc GILD.OQ +8.3% Advanced Micro Devices Inc AMD.OQ +5.2% Sirius XM Holdings Inc SIRI.OQ +3.6% Cognizant Technology Solutions Corp CTSH.OQ +3.5% Workday Inc WDAY.OQ +3.1% Bottom Performers Percent Change Qualcomm Inc QCOM.OQ -5.1% Micron Technology Inc MU.OQ -5.1% Microchip Technology Inc MCHP.OQ -4.5% ON Semiconductor Corp ON.OQ -4.2% Broadcom Inc AVGO.OQ -3.3% Th
B
C
G
M
Q
A
M
O
S
U
W

S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT

BUZZ - S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT S&P 500 .SPX Top Performers Percent Change Gilead Sciences Inc GILD.OQ +8.4% Accenture PLC ACN.N +7.9% Epam Systems Inc EPAM.N +6.3% Salesforce Inc CRM.N +5.1% WestRock Co WRK.N +4.8% Bottom Performers Percent Change Jabil Inc JBL.N -11.2% Enphase Energy Inc ENPH.OQ -8.7% Chipo
C
G
M
Q
S
U
E
W



شرائط

مشہور اثاثے

دستبرداری: XM Group کے ادارے ہماری آن لائن تجارت کی سہولت تک صرف عملدرآمد کی خدمت اور رسائی مہیا کرتے ہیں، کسی شخص کو ویب سائٹ پر یا اس کے ذریعے دستیاب کانٹینٹ کو دیکھنے اور/یا استعمال کرنے کی اجازت دیتا ہے، اس پر تبدیل یا توسیع کا ارادہ نہیں ہے ، اور نہ ہی یہ تبدیل ہوتا ہے یا اس پر وسعت کریں۔ اس طرح کی رسائی اور استعمال ہمیشہ مشروط ہوتا ہے: (i) شرائط و ضوابط؛ (ii) خطرہ انتباہات؛ اور (iii) مکمل دستبرداری۔ لہذا اس طرح کے مواد کو عام معلومات سے زیادہ کے طور پر فراہم کیا جاتا ہے۔ خاص طور پر، براہ کرم آگاہ رہیں کہ ہماری آن لائن تجارت کی سہولت کے مندرجات نہ تو کوئی درخواست ہے، اور نہ ہی فنانشل مارکیٹ میں کوئی لین دین داخل کرنے کی پیش کش ہے۔ کسی بھی فنانشل مارکیٹ میں تجارت میں آپ کے سرمائے کے لئے ایک خاص سطح کا خطرہ ہوتا ہے۔

ہماری آن لائن تجارتی سہولت پر شائع ہونے والے تمام مٹیریل کا مقصد صرف تعلیمی/معلوماتی مقاصد کے لئے ہے، اور اس میں شامل نہیں ہے — اور نہ ہی اسے فنانشل، سرمایہ کاری ٹیکس یا تجارتی مشورے اور سفارشات؛ یا ہماری تجارتی قیمتوں کا ریکارڈ؛ یا کسی بھی فنانشل انسٹرومنٹ میں لین دین کی پیشکش؛ یا اسکے لئے مانگ؛ یا غیر متنازعہ مالی تشہیرات پر مشتمل سمجھا جانا چاہئے۔

کوئی تھرڈ پارٹی کانٹینٹ، نیز XM کے ذریعہ تیار کردہ کانٹینٹ، جیسے: راۓ، خبریں، تحقیق، تجزیہ، قیمتیں اور دیگر معلومات یا اس ویب سائٹ پر مشتمل تھرڈ پارٹی کے سائٹس کے لنکس کو "جیسے ہے" کی بنیاد پر فراہم کیا جاتا ہے، عام مارکیٹ کی تفسیر کے طور پر، اور سرمایہ کاری کے مشورے کو تشکیل نہ دیں۔ اس حد تک کہ کسی بھی کانٹینٹ کو سرمایہ کاری کی تحقیقات کے طور پر سمجھا جاتا ہے، آپ کو نوٹ کرنا اور قبول کرنا ہوگا کہ یہ کانٹینٹ سرمایہ کاری کی تحقیق کی آزادی کو فروغ دینے کے لئے ڈیزائن کردہ قانونی تقاضوں کے مطابق نہیں ہے اور تیار نہیں کیا گیا ہے، اسی طرح، اس پر غور کیا جائے گا بطور متعلقہ قوانین اور ضوابط کے تحت مارکیٹنگ مواصلات۔ براہ کرم یقینی بنائیں کہ آپ غیر آزاد سرمایہ کاری سے متعلق ہماری اطلاع کو پڑھ اور سمجھ چکے ہیں۔ مذکورہ بالا معلومات کے بارے میں تحقیق اور رسک وارننگ ، جس تک رسائی یہاں حاصل کی جا سکتی ہے۔

خطرے کی انتباہ: آپکا سرمایہ خطرے پر ہے۔ ہو سکتا ہے کہ لیورج پروڈکٹ سب کیلیے موزوں نہ ہوں۔ براہ کرم ہمارے مکمل رسک ڈسکلوژر کو پڑھیے۔